Evidence map›Paper›PMID 35705591›Full record

ArticleScientific reports2022

Label-free prediction of cell painting from brightfield images.

Jan Oscar Cross-Zamirski, Elizabeth Mouchet, Guy Williams, Carola-Bibiane Schönlieb, Riku Turkki, Yinhai Wang

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Deep Learning-Powered Scalable Cancer Organ Chip for Cancer Precision Medicine.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Alternate dyes for image-based profiling assays.SLAS discovery : advancing life sciences R & D · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jan Oscar Cross-ZamirskiDepartment for Applied Mathematics and Theoretical Physics, University of Cambridge, Cambridge, CB3 0WA, UK. jc856@cam.ac.uk.
Elizabeth MouchetDiscovery Sciences, R&D, AstraZeneca, Alderley Park, Cheshire, SK10 4TG, UK.
Guy WilliamsDiscovery Sciences, R&D, AstraZeneca, Alderley Park, Cheshire, SK10 4TG, UK.
Carola-Bibiane SchönliebDepartment for Applied Mathematics and Theoretical Physics, University of Cambridge, Cambridge, CB3 0WA, UK.
Riku Turkki *Discovery Sciences, R&D, AstraZeneca, Gothenburg, Pepparedsleden 1, 431 50, Mölndal, Sweden.
Yinhai Wang *Discovery Sciences, R&D, AstraZeneca, Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, UK.

Funding

Biotechnology and Biological Sciences Research Council 21-3688Wellcome Trust 215733/Z/19/ZWellcome Trust 221633/Z/20/Z
6 · The paper itself

Abstract

Cell Painting is a high-content image-based assay applied in drug discovery to predict bioactivity, assess toxicity and understand mechanisms of action of chemical and genetic perturbations. We investigate label-free Cell Painting by predicting the five fluorescent Cell Painting channels from brightfield input. We train and validate two deep learning models with a dataset representing 17 batches, and we evaluate on batches treated with compounds from a phenotypic set. The mean Pearson correlation coefficient of the predicted images across all channels is 0.84. Without incorporating features into the model training, we achieved a mean correlation of 0.45 with ground truth features extracted using a segmentation-based feature extraction pipeline. Additionally, we identified 30 features which correlated greater than 0.8 to the ground truth. Toxicity analysis on the label-free Cell Painting resulted a sensitivity of 62.5% and specificity of 99.3% on images from unseen batches. We provide a breakdown of the feature profiles by channel and feature type to understand the potential and limitations of label-free morphological profiling. We demonstrate that label-free Cell Painting has the potential to be used for downstream analyses and could allow for repurposing imaging channels for other non-generic fluorescent stains of more targeted biological interest.

Indexed as

Biological AssayDrug DiscoveryImage Processing, Computer-Assisted

Identifiers

PMID35705591
PMCPMC9200748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.